Abbot Financial Management’s Pfizer PFE Stock Holding History

Abbot Financial Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-422	Closed	-$12K	–	134
2020 Q2	$12K	Buy	+422	New	+$14.3K	0.01%	127

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Abbot Financial Management's PFE Position: Q1 2026 in Review

Abbot Financial Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 19,450 shares — an estimated $484K sold.

Abbot Financial Management first reported a position in PFE in Q2 2017 and held it in 35 quarters. The position peaked at $3.52M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Abbot Financial Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
Abbot Financial Management sold 19,450 Pfizer shares in Q1 2026, an estimated $484K.
Abbot Financial Management first reported a position in Pfizer in Q2 2017 and held it in 35 quarters.
Abbot Financial Management's Pfizer position peaked at $3.52M in Q4 2021.
2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Abbot Financial Management's 13F filing for Q1 2026, filed 13 May 2026.